BharathiReddyBharathi Reddy41.78927490000000-87.60125000000000656Reddy, BharathiAssociate Professorplugins:TwitterTwitterprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000520Chemicals & Drugs570.990668alpha-GlucosidasesD001552Chemicals & Drugs33890.93509BenzazepinesD005919PhysiologyProcedures873840.862514Glomerular Filtration RateAuthorship 111258128784653Reddy BV, Chapman ABClinical journal of the American Society of Nephrology : CJASNA Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2017 10 06; 12(10):1695-1698.Clin J Am Soc Nephrol2017-08-07T00:00:002017A Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney Disease.Authorship 260742Authorship 262884Authorship 27790115632219Tang IY, Cox DS, Patel K, Reddy BV, Nahlik L, Trevino S, Murray PTThe Annals of pharmacotherapyArgatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia. Ann Pharmacother. 2005 Feb; 39(2):231-6.Ann Pharmacother2005-01-04T00:00:002005Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.15569338Murray PT, Reddy BV, Grossman EJ, Hammes MS, Trevino S, Ferrell J, Tang I, Hursting MJ, Shamp TR, Swan SKKidney internationalA prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease. Kidney Int. 2004 Dec; 66(6):2446-53.Kidney Int2004-12-01T00:00:002004A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease.16131539Reddy BV, Grossman EJ, Trevino SA, Hursting MJ, Murray PTThe Annals of pharmacotherapyArgatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy. Ann Pharmacother. 2005 Oct; 39(10):1601-5.Ann Pharmacother2005-08-30T00:00:002005Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.D016891Disorders191360.873425Polycystic Kidney, Autosomal DominantD065092Chemicals & Drugs11290.976489Antidiuretic Hormone Receptor Antagonistshttps://biosciences.uchicago.edu/UChicago Bioscienceshttps://redcap.uchicago.edu/redcap_v9.5.36/DataExport/index.php?pid=11197Research OpportunitiesjaykoynerMedicineUniversity of ChicagoJayKoynerJay Koyner41.78927490000000-87.601250000000001019Koyner, JayProfessorMaryHammesMary Hammes41.78927490000000-87.601250000000001249Hammes, MaryAssociate ProfessorGeorgeBakris0GBoa7McCszMknJtY0fp/Cv/+94=George Bakris41.78927490000000-87.601250000000001393Bakris, GeorgeProfessorAnna L.ZismanAnna L. Zisman41.78927490000000-87.601250000000001478Zisman, Anna L.Associate ProfessorTipu S.PuriTipu S. Puri41.78927490000000-87.601250000000001602Puri, Tipu S.Associate ProfessorKristinCaffreyKristin Caffrey41.78927490000000-87.601250000000001948Caffrey, KristinResearch Assistant ProfessorMichelle A.Josephson2mNjBLIQCeT5hHlsaUXv9Gq0+s+oMichelle A. Josephson41.78927490000000-87.601250000000002650Josephson, Michelle A.Professor1.653680.014757447research areas1.78430.01637482coauthor of41.76231.2631460similar to117selected publicationsStuartSpragueStuart M. Sprague41.78927490000000-87.60125000000000875Sprague, StuartClinical Professortrue1Clinical ProfessorClinical Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Research Assistant ProfessorResearch Assistant ProfessorAuthorship 79574126003607Reddy B, Chapman ABAmerican journal of kidney diseases : the official journal of the National Kidney FoundationAcute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy? Am J Kidney Dis. 2015 Jun; 65(6):811-3.Am J Kidney Dis2015-06-01T00:00:002015Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy?Medicine-EndocrinologyArleneChapman1mBqA6AFFMzMknJtY0fp/Cv/+94=Arlene Chapman0.000000000000000.000000000000003167Chapman, ArleneProfessorChicago60637ILAuthorship 905241127259053Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, Edwards ME, Madsen CD, Mauritz SR, Banks CJ, Baheti S, Reddy B, Herrero JI, Bañales JM, Hogan MC, Tasic V, Watnick TJ, Chapman AB, Vigneau C, Lavainne F, Audrézet MP, Ferec C, Le Meur Y, Torres VE, Genkyst Study Group, HALT Progression of Polycystic Kidney Disease Group, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease, Harris PCAmerican journal of human geneticsMutations in GANAB, Encoding the Glucosidase IIa Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease. Am J Hum Genet. 2016 06 02; 98(6):1193-1207.Am J Hum Genet2016-06-02T00:00:002016Mutations in GANAB, Encoding the Glucosidase IIa Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.Authorship 97624127034070Reddy BV, Chapman ABPediatric nephrology (Berlin, Germany)The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatr Nephrol. 2017 01; 32(1):31-42.Pediatr Nephrol2016-03-31T00:00:002016The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.Medicine-NephrologyRitaMcGillRita McGill0.000000000000000.000000000000003412McGill, RitaAssociate Professor